Select Page

PERJETA ™ (pertuzumab) Injection, for intravenous use Initial U.S. Approval: 2012

PERJETA ™ (pertuzumab) Injection, for intravenous use Initial U.S. Approval: 2012

PERJETA is a prescription medicine. PERJETA is used to treat HER2-positive early breast cancer

INDICATIONS AND USAGE
PERJETA is a HER2/neu receptor antagonist indicated in combination withtrastuzumab and docetaxel for the treatment of patients with HER2-positive metastatic breast cancer who have not received prior anti-HER2 therapy or chemotherapy for metastatic disease.
DOSAGE FORMS & STRENGTHS
420 mg/14 mL single-use vial.
Manufactured By: Genentech
Prescribing Information URL: Click Here

Procedure to buy PERJETA ™ (pertuzumab) Injection?
To buy PERJETA ™ (pertuzumab) Injection, patients can simply fill the order form or can send mail at info@bioniquehealthcare.com. or can also send Whatsapp message at +91 96677 50889. You will get reply within few hours with pricing and procedure details. Note:- the order will be confirmed only after the receipt of valid prescription of doctor.

Category:

Pertuzumab (also called 2C4, trade name Perjeta) is a monoclonal antibody used in combination with trastuzumab and docetaxel for the treatment of metastatic HER2-positive breast cancer; it also used in the same combination as a neoadjuvant in early HER2-positive breast cancer.

Pertuzumab is administered as an intravenous infusion in combination with trastuzumab and docetaxel as a first line treatment for HER2-positive metastatic breast cancer. It is also used in the same combination as a neoadjuvant (given to reduce the size of a tumor, prior to surgery or radiation) for HER2-positive early breast cancer; as of 2016 this use had not been shown to increase survival.

Documentation

  1. Doctor’s Prescription – We would require prescription from registered medical practitioner stating product name, dosage, duration of treatment and diagnosis.
  2. Patient’s Medical history – We would require all test reports and medical reports of the patient for last 3 months.
  3. Patient’s Identity card – We will require scan copy of patient’s identity card and proof of residence to initiate documentation process. you can use copy of passport, driving license, employee ID card or any photo id document as your identity card.

For Overseas Patient

Can I get anti-cancer medicines even if I am not based in India?

Almost all countries across the world have provisions for granting access to drugs prior to marketing approval for personal use for patients who have exhausted all other treatment options available in their country. The Bionique Healthcare can help patients in accessing/importing Ant-cancer medicines, unapproved in their home country against a legitimate prescription and in conformity with all local laws and regulations of their home country.

Send your query to find the best price of –

PERJETA ™ (pertuzumab) Injection in South East Asia – China (Beijing, Chongqing, Shanghai, Tianjin and Shenzhen), Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong.
PERJETA ™ (pertuzumab) Injection in United Arab Emirates – Iraq, Iran, Saudi Arabia, Jordan.
PERJETA ™ (pertuzumab) Injection in North America – Mexico.
PERJETA ™ (pertuzumab) Injection in South America – Argentina, Brazil, Chile, Colombia, Peru, Venezuela.
PERJETA ™ (pertuzumab) Injection in Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia.
PERJETA ™ (pertuzumab) Injection in Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia.
PERJETA ™ (pertuzumab) Injection in African Countries – Algeria, Mauritius, Uganda, Zimbabwe.
PERJETA ™ (pertuzumab) Injection in Australia and New Zealand.

For Indian Patient

Ani-Cancer PERJETA ™ (pertuzumab) Injection are prescription drug. 

We facilitate by-

  • Helping in documentation to import the medicine for personal use.
  • Finding Genuine and reliable source in USA, Europe and Japan.
  • Ensuring 100% transparency.

PERJETA ™ (pertuzumab) Injection can be shipped to Ahmedabad, Bangalore, Chennai, Cochin, Hyderabad, Delhi, Haryana, Jaipur, Jammu and Kashmir, Himachal Pradesh, Kolkata, Lucknow, Mumbai, Pune, Punjab and other cities in India. Bionique Healthcare does not manufacture, supply, re-sell or retail any drugs or medicines. 

Reviews

There are no reviews yet.

Be the first to review “PERJETA ™ (pertuzumab) Injection, for intravenous use Initial U.S. Approval: 2012”

Your email address will not be published. Required fields are marked *

Anti-Cancer Medicine Supplier.

Bionique Healthcare is a consulting pharmaceutical company which assist Patients in accessing medicines in India. Bionique Healthcare facilitates such access only against valid prescriptions in conformity with all local laws and regulations.

Patients/ Clinicians / Researchers can contact Bionique at +91 9667750889 or write to at – info@bioniquehealthcare.com.

Product Disclaimer

Bionique Healthcare does not manufacture, supply, re-sell or retail any drugs or medicines. All trademarks and other intellectual property in relation to drugs and medicines supplied to you by suppliers are owned by their respective manufacturer or licensee. 

Bionique Healthcare does not lay any claim on them.